Antimicrobial Susceptibility and Clonal Relationship of Tetracycline Resistance Genes in netF-Positive Clostridium perfringens.

NetF-producing type A Clostridium perfringens, a pathotype of C. perfringens, causes necrotizing enteritis in neonatal foals and necrotizing and hemorrhagic enteritis in dogs. Recent core genome multilocus sequence typing study revealed that netF+ C. perfringens strains belong to two distinct clonal populations (clonal complexes I and II). There are no reports on susceptibility to antimicrobial drugs of isolates from this pathotype. The susceptibility to 13 different antimicrobial drugs of 49 netF+ strains recovered from foals or dogs with necrotizing enteritis in Canada, the United States, and Switzerland was assessed using a commercial microdilution panel designed for anaerobic human pathogens. All isolates were highly susceptible to 12 antimicrobial agents, including all beta-lactams tested, such as penicillin G and ampicillin, as well as clindamycin, chloramphenicol, and metronidazole. The isolates consistently presented a reduced susceptibility or resistance to tetracycline, which was associated with previously described tetracycline resistance genes. Clonal complex I isolates (n = 41) possessed the tetA408(P) gene, whereas clonal complex II isolates (n = 8) possessed the tetA(P)-tetB(P) genes and were more likely to be fully resistant.

[1]  Robert J. Moore,et al.  Expansion of the Clostridium perfringens toxin-based typing scheme. , 2018, Anaerobe.

[2]  J. Rood,et al.  Antibiotic resistance plasmids and mobile genetic elements of Clostridium perfringens. , 2018, Plasmid.

[3]  K. Seo,et al.  Prevalence, toxin gene profile, antibiotic resistance, and molecular characterization of Clostridium perfringens from diarrheic and non-diarrheic dogs in Korea , 2018, Journal of veterinary science.

[4]  J. Blanco,et al.  Clostridium perfringens Type A Isolates of Animal Origin with Decreased Susceptibility to Metronidazole Show Extensive Genetic Diversity. , 2017, Microbial drug resistance.

[5]  J. Prescott,et al.  NetF-producing Clostridium perfringens: Clonality and plasmid pathogenicity loci analysis. , 2017, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[6]  J. Prescott,et al.  Plasmid Characterization and Chromosome Analysis of Two netF+ Clostridium perfringens Isolates Associated with Foal and Canine Necrotizing Enteritis , 2016, PloS one.

[7]  J. Prescott,et al.  A Novel Pore-Forming Toxin in Type A Clostridium perfringens Is Associated with Both Fatal Canine Hemorrhagic Gastroenteritis and Fatal Foal Necrotizing Enterocolitis , 2015, PloS one.

[8]  M. Jacques,et al.  Biofilm formation of Clostridium perfringens and its exposure to low-dose antimicrobials , 2014, Front. Microbiol..

[9]  Patricia M. Dowling,et al.  Antimicrobial Therapy in Veterinary Medicine: Giguère/Antimicrobial Therapy in Veterinary Medicine , 2013 .

[10]  V. Perreten,et al.  Antimicrobial susceptibility of canine Clostridium perfringens strains from Switzerland. , 2012, Schweizer Archiv fur Tierheilkunde.

[11]  A. German,et al.  First-choice therapy for dogs presenting with diarrhoea in clinical practice , 2010, Veterinary Record.

[12]  J. Foley,et al.  Determination of the prevalence of antimicrobial resistance genes in canine Clostridium perfringens isolates. , 2006, Veterinary microbiology.

[13]  K. G. Magdesian,et al.  Neonatal Foal Diarrhea , 2005, Veterinary Clinics of North America: Equine Practice.

[14]  C. Greko,et al.  Antimicrobial susceptibility of Swedish, Norwegian and Danish isolates of Clostridium perfringens from poultry, and distribution of tetracycline resistance genes. , 2004, Veterinary microbiology.

[15]  F. Haesebrouck,et al.  Susceptibility of Clostridium perfringens strains from broiler chickens to antibiotics and anticoccidials , 2004, Avian pathology : journal of the W.V.P.A.

[16]  L. Devriese,et al.  Susceptibility of Clostridium perfringens of animal origin to fifteen antimicrobial agents , 1980 .